Your browser doesn't support javascript.
loading
Characteristics associated with patient-reported treatment success in psoriatic arthritis.
Samuel, Christeen; Finney, Amanda; Grader-Beck, Thomas; Haque, Uzma; Miller, John; Grieb, Suzanne M; Prichett, Laura; Orbai, Ana-Maria.
Affiliation
  • Samuel C; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Finney A; Biostatistics, Epidemiology, and Data Management (BEAD) Core, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Grader-Beck T; Department of Medicine, Division of Rheumatology, Arthritis Center, Johns Hopkins University School of Medicine, Maryland, United States of America, Psoriatic Arthritis Program, Baltimore.
  • Haque U; Department of Medicine, Division of Rheumatology, Arthritis Center, Johns Hopkins University School of Medicine, Maryland, United States of America, Psoriatic Arthritis Program, Baltimore.
  • Miller J; Department of Medicine, Division of Rheumatology, Arthritis Center, Johns Hopkins University School of Medicine, Maryland, United States of America, Psoriatic Arthritis Program, Baltimore.
  • Grieb SM; Patient Research Partner, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Prichett L; Biostatistics, Epidemiology, and Data Management (BEAD) Core, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Orbai AM; Department of Medicine, Division of Rheumatology, Arthritis Center, Johns Hopkins University School of Medicine, Maryland, United States of America, Psoriatic Arthritis Program, Baltimore.
Article in En | MEDLINE | ID: mdl-38460549
ABSTRACT

OBJECTIVES:

To determine characteristics associated with patient-reported treatment success in psoriatic arthritis (PsA).

METHODS:

Rheumatologist-diagnosed PsA patients fulfilling the CASPAR classification were recruited from a single center. PsA outcome measures included 66/68 swollen/tender joint counts, Leeds/SPARCC dactylitis/enthesitis indices, psoriasis body surface area (BSA), and patient-reported outcomes (PROs) including PROMIS. The primary outcome was a patient-reported item "Today, considering the level of control of your psoriatic arthritis and psoriasis, do you consider your treatment has been successful?" Descriptive and multivariate logistic regression analyses identified clinical predictors of patient-reported treatment success. Patient-reported reasons for lack of treatment success were explored.

RESULTS:

A total of 178 participants had a baseline visit. Mean (SD) CASPAR score was 3.7 (0.9), age 51.7 (13.5) years, and BMI 31.3 (7.2) kg/m2. Fifty-two percent were women, and 86.0% white. Treatment success was reported by 116/178(65%) patients in the analytic cohort. Among 76 patients who reported treatment failure, the most frequently selected reasons for lack of success were pain (n = 55, 72.4%), fatigue (n = 46, 60.5%), inflamed joints (n = 40, 52.6%), and stiffness (n = 40, 52.6%). Overall, 105 participants had complete data across variables in the logistic regression models. Patient-reported treatment success was independently associated with the 66-swollen/68-tender joint counts, psoriasis BSA, PROs (pain interference, physical function, fatigue), and TNF-inhibitor therapy, after controlling for BMI and demographics.

CONCLUSION:

Patient-reported treatment success in PsA may be achieved through improvement of inflammatory arthritis, psoriasis, pain, physical function, fatigue, and the use ofTNF-inhibitors. Patients reported treatment failure was most commonly due to symptoms of pain, fatigue and stiffness.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2024 Document type: Article Affiliation country: